Soybeans Close Mixed: Front Months Dip, Deferred Contracts Gain
Soybean futures concluded Monday's trading session with a mixed performance, as front-month contracts saw declines while deferred positions posted fractional gains. Cash...

Soybean futures concluded Monday's trading session with a mixed performance, as front-month contracts saw declines while deferred positions posted fractional gains. Cash...

The US has temporarily waived sanctions, allowing Iran to sell oil in US dollars for the first time in decades, following talks...

Former Fed chair Alan Greenspan maintained a profound intellectual and personal friendship with novelist Ayn Rand, a relationship that spanned decades and...

Financial expert Barry Ritholtz recently discussed market euphoria, SpaceX's IPO valuation, AI industry's circular deals, and hedging strategies.

AI is transforming payments, making features like personalization baseline expectations while elevating foundational infrastructure. Spreedly's Judd Howard highlights the shift from "aspirin"...

High oil prices, exacerbated by geopolitical events, are driving a significant surge in Chinese electric vehicle sales across the developing world, yet...

China has announced sanctions on 10 American defense companies, restricting exports of 'dual-use' items in retaliation for U.S. measures against Chinese tech...

Island Passage Exploration and Isina Resource Holdings have paid K201,100 to customary landowners for work on the EL02 Project in Bougainville.

Microsoft CEO Satya Nadella calls for an "AI reset," advocating for broader access and lower costs instead of a race to build...

Istanbul-based FinTech Midas has applied for an electronic money institution license, aiming to launch a digital wallet and prepaid-card business. This strategic...

Treasuries declined and yields rose after President Donald Trump threatened military action against Iran, sending oil prices higher and prompting investors to...

MoonLake Immunotherapeutics (MLTX) reported strong one-year Phase 3 trial results for sonelokimab in hidradenitis suppurativa, planning a U.S. FDA filing this fall.